Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion

Women-Led Digital Health: The Women Behind Digital Health Innovations and the Journey to Success

MIB Agents Selects OncoLens to Support and Expand its TURBO Program Globally

The Desmoid Tumor Research Foundation Closes Care Gaps through Virtualized Multidisciplinary Cancer Care Platform

OncoLens Platform Critical to Meeting the CoC’s Continuous Quality Improvement Requirements